Logo image of FRSX

FORESIGHT AUTONOMOUS-SP ADR (FRSX) Stock Fundamental Analysis

NASDAQ:FRSX - Nasdaq - US3455232039 - ADR - Currency: USD

0.3589  +0 (+0.14%)

After market: 0.359 +0 (+0.03%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to FRSX. FRSX was compared to 80 industry peers in the Automobile Components industry. While FRSX has a great health rating, there are worries on its profitability. FRSX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

FRSX had negative earnings in the past year.
In the past year FRSX has reported a negative cash flow from operations.
FRSX had negative earnings in each of the past 5 years.
In the past 5 years FRSX always reported negative operating cash flow.
FRSX Yearly Net Income VS EBIT VS OCF VS FCFFRSX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of FRSX (-114.29%) is worse than 98.75% of its industry peers.
The Return On Equity of FRSX (-183.61%) is worse than 91.25% of its industry peers.
Industry RankSector Rank
ROA -114.29%
ROE -183.61%
ROIC N/A
ROA(3y)-91.84%
ROA(5y)-66.89%
ROE(3y)-126.58%
ROE(5y)-88.71%
ROIC(3y)N/A
ROIC(5y)N/A
FRSX Yearly ROA, ROE, ROICFRSX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

The Gross Margin of FRSX (60.55%) is better than 100.00% of its industry peers.
FRSX's Gross Margin has improved in the last couple of years.
FRSX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.09%
GM growth 5YN/A
FRSX Yearly Profit, Operating, Gross MarginsFRSX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

More info and screens

7

2. Health

2.1 Basic Checks

FRSX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FRSX has been increased compared to 1 year ago.
FRSX has more shares outstanding than it did 5 years ago.
FRSX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FRSX Yearly Shares OutstandingFRSX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
FRSX Yearly Total Debt VS Total AssetsFRSX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -21.18, we must say that FRSX is in the distress zone and has some risk of bankruptcy.
FRSX has a worse Altman-Z score (-21.18) than 96.25% of its industry peers.
There is no outstanding debt for FRSX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -21.18
ROIC/WACCN/A
WACC9.07%
FRSX Yearly LT Debt VS Equity VS FCFFRSX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 4.50 indicates that FRSX has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.50, FRSX belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
FRSX has a Quick Ratio of 4.50. This indicates that FRSX is financially healthy and has no problem in meeting its short term obligations.
FRSX has a Quick ratio of 4.50. This is amongst the best in the industry. FRSX outperforms 95.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.5
Quick Ratio 4.5
FRSX Yearly Current Assets VS Current LiabilitesFRSX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 57.01% over the past year.
FRSX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.27%.
Measured over the past years, FRSX shows a very strong growth in Revenue. The Revenue has been growing by 53.73% on average per year.
EPS 1Y (TTM)57.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.65%
Revenue 1Y (TTM)-12.27%
Revenue growth 3Y53.73%
Revenue growth 5YN/A
Sales Q2Q%-26.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FRSX Yearly Revenue VS EstimatesFRSX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 100K 200K 300K 400K 500K
FRSX Yearly EPS VS EstimatesFRSX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2020 2021 -2 -4 -6 -8 -10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FRSX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FRSX Price Earnings VS Forward Price EarningsFRSX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FRSX Per share dataFRSX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FRSX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FORESIGHT AUTONOMOUS-SP ADR

NASDAQ:FRSX (8/8/2025, 8:00:00 PM)

After market: 0.359 +0 (+0.03%)

0.3589

+0 (+0.14%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)11-25 2022-11-25/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change-1.14%
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap6.97M
Analysts82.86
Price TargetN/A
Short Float %1.32%
Short Ratio0.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.99
P/FCF N/A
P/OCF N/A
P/B 1.15
P/tB 1.15
EV/EBITDA N/A
EPS(TTM)-0.58
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS0.02
BVpS0.31
TBVpS0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -114.29%
ROE -183.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.55%
FCFM N/A
ROA(3y)-91.84%
ROA(5y)-66.89%
ROE(3y)-126.58%
ROE(5y)-88.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.09%
GM growth 5YN/A
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 14.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.5
Quick Ratio 4.5
Altman-Z -21.18
F-Score3
WACC9.07%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)32.03%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.27%
Revenue growth 3Y53.73%
Revenue growth 5YN/A
Sales Q2Q%-26.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.93%
OCF growth 3YN/A
OCF growth 5YN/A